A recently-published Center for Gene Therapy study is garnering national and international attention
In March we highlighted a Center for Gene Therapy study appearing in Annals of Neurology that focused on a newborn screening model for the life-threatening disease, Duchenne muscular dystrophy. Read about the study.
These findings continue to gain recognition on the national and international landscape. Recently, the American Neurological Association highlighted the study in a publication sent to national and international members of prestigious neurological societies. This is one example of how our leadership in gene therapy and neuromuscular research continues to impress.
Read more about what it took to pull off this 4-year, multiple-site clinical research study screening 37,649 newborn babies.